| 1. |  1Elevan Biopharmaceuticals, Inc. Fishers, Indiana, USA | CDMO | Discovery | VIEW |
| 2. |  3PBIOVIAN Noáin (Navarra), Spain | CDMO | Commercial | VIEW |
| 3. |  3PBIOVIAN Turku, Finland (Biovian) / Pamplona, Spain (3P) - now pan-European | CDMO | CDMO - supports clients' pipelines from Discovery through Commercial | VIEW |
| 4. |  3S Pharma Services Bucharest, Romania | CRO | Commercial | VIEW |
| 5. |  3SBio Inc. Shenyang, China | Biotech | Phase 3 | VIEW |
| 6. |  4 Animals AlsterScience GmbH Hamburg, Germany | Biotech | Preclinical | VIEW |
| 7. |  4D Pharma plc Leeds, United Kingdom | Biotech | Preclinical to Phase II (at time of administration) | VIEW |
| 8. |  5C Network Bengaluru, India | Digital Health | Series A | VIEW |
| 9. |  5QBD-Biotech Aydat, France | CRO | Service Provider | VIEW |
| 10. |  ABX advanced biochemical compounds Radeberg, Germany | CDMO | Commercial | VIEW |
| 11. |  ADARx Pharmaceuticals San Diego, USA | Biotech | Phase 3 | VIEW |
| 12. |  AGS Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 13. |  AItewan BioMedical Technology Inc. Taipei, Taiwan | Digital Health | Commercial | VIEW |
| 14. |  ALX Oncology South San Francisco, United States | Biotech | Phase 1 / Phase 2 | VIEW |
| 15. |  AMS Advanced Medical Services GmbH Mannheim, Germany | CRO | - | VIEW |
| 16. |  ANSTO (Australian Nuclear Science and Technology Organisation) Sydney, Australia | Biotech | Commercial | VIEW |
| 17. |  ARENSIA Exploratory Medicine Dusseldorf, Germany | CRO | Commercial | VIEW |
| 18. |  AUSTAR Lifesciences Limited Shanghai, China | CDMO | Commercial | VIEW |
| 19. |  AWINSA Life Sciences New Delhi, India | CRO | - | VIEW |
| 20. |  AbCellera Vancouver, Canada | Biotech | Phase 2 | VIEW |
| 21. |  Abbisko Therapeutics Shanghai, China | Biotech | Phase 3 | VIEW |
| 22. |  Abcuro, Inc. Newton, Massachusetts, USA | Biotech | Phase 2/3 | VIEW |
| 23. |  Abdera Therapeutics South San Francisco, USA / Vancouver, Canada | Biotech | Phase 1 | VIEW |
| 24. |  Abzena Cambridge, United Kingdom | CDMO | Commercial | VIEW |
| 25. |  Accelera S.r.l. Nerviano (Milan), Italy | CRO | Discovery | VIEW |
| 26. |  Accent Therapeutics Lexington, Massachusetts, United States | Biotech | Phase 1/2 | VIEW |
| 27. |  Access Community Clinical Trials Baton Rouge, Louisiana | CRO | Commercial | VIEW |
| 28. |  Acelot South San Francisco, California, USA | Biotech | Preclinical | VIEW |
| 29. |  Acepodia Alameda, USA / Taipei, Taiwan | Biotech | Phase 1 | VIEW |
| 30. |  Acerand Therapeutics Carmel, USA / Shanghai, China | Biotech | Phase 1/2 | VIEW |
| 31. |  Acme Generics Chandigarh, India | CDMO | Commercial | VIEW |
| 32. |  Acrotech Biopharma Inc. East Windsor, New Jersey, USA | Pharma | Commercial | VIEW |
| 33. |  Acurion Health San Diego, USA | Diagnostics | Commercial | VIEW |
| 34. |  Adamed Pharma Pieńków, Poland | Pharma | Commercial | VIEW |
| 35. |  Adium (Adium Paraguay / Fapasa) Asunción, Paraguay | Pharma | Commercial | VIEW |
| 36. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 37. |  AdvantiGen Biosciences Madison, WI, United States | Biotech | Discovery | VIEW |
| 38. |  Advanz Pharma London, United Kingdom | Pharma | Commercial|Phase 2|Phase 3 | VIEW |
| 39. |  | CRO | - | VIEW |
| 40. |  Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA) | Biotech | Clinical | VIEW |
| 41. |  Agilent Technologies Santa Clara, United States | Diagnostics | Commercial | VIEW |
| 42. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 43. |  Aitia Somerville, Massachusetts, USA | Biotech | Discovery | VIEW |
| 44. |  Aixial Group Boulogne-Billancourt, France | CRO | - | VIEW |
| 45. |  Aizant Drug Research Solutions Pvt. Ltd. Hyderabad, India | CDMO | Discovery | VIEW |
| 46. |  Akeso, Inc. Guangdong, China | Biotech | Commercial | VIEW |
| 47. |  Alchemab Therapeutics Cambridge, United Kingdom | Biotech | Phase 1 | VIEW |
| 48. |  | CDMO | Commercial | VIEW |
| 49. |  Alembic Pharmaceuticals Limited Vadodara, India | Pharma | Commercial | VIEW |
| 50. |  Aleon Pharma International, Inc. Parsippany, New Jersey, USA | CRO | N/A | VIEW |
| 51. |  Alkem Laboratories Mumbai, India | Pharma | Commercial | VIEW |
| 52. |  Allotera Therapeutics St. Louis, USA | Biotech | Pivotal | VIEW |
| 53. |  Allotera Therapeutics (formerly Wugen, Inc.) St. Louis, USA | Biotech | Phase 2 | VIEW |
| 54. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 55. |  Allygen Biosciences Shanghai, China | Biotech | Preclinical | VIEW |
| 56. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 57. |  AlphaGen Therapeutics Shanghai, China | Biotech | Preclinical | VIEW |
| 58. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 59. |  Alvotech Luxembourg, Luxembourg | Biotech | Commercial | VIEW |
| 60. |  Amgen Thousand Oaks, California, United States | Biotech | Discovery through Commercial | VIEW |
| 61. |  Ami Organics Limited Surat, India | CDMO | Commercial | VIEW |
| 62. |  Amneal Pharmaceuticals Bridgewater, New Jersey, USA | Pharma | Commercial | VIEW |
| 63. |  Amoy Diagnostics Co., Ltd. Xiamen, China | Diagnostics | Commercial | VIEW |
| 64. |  Amoy Diagnostics Co., Ltd. Xiamen, China | Diagnostics | Commercial | VIEW |
| 65. |  Anavex Life Sciences Corp. New York, United States | Biotech | Phase 2|Phase 3 | VIEW |
| 66. |  Angal Biotechnologies Ltd. Suzhou, China | Biotech | Preclinical | VIEW |
| 67. |  Anocca AB Södertälje, Sweden | Biotech | Phase 1 | VIEW |
| 68. |  Antares Therapeutics Boston, USA | Biotech | Preclinical | VIEW |
| 69. |  Anthem Biosciences Bangalore, India | CDMO | Commercial | VIEW |
| 70. |  Anwita Biosciences, Inc. San Carlos, USA | Biotech | Phase 1 | VIEW |
| 71. |  Apeiron Therapeutics (GT Apeiron LLC) Burlingame, USA / Shanghai, China | Biotech | Phase 1 | VIEW |
| 72. |  Apotex Inc. Toronto, Canada | Pharma | Commercial | VIEW |
| 73. |  Applied Pathology Systems Worcester, Massachusetts, USA | CRO | Commercial | VIEW |
| 74. |  Applied Process Technology, Inc. (AP Tech) Elkton, Maryland, USA | CDMO | Commercial | VIEW |
| 75. |  Aprogen Seongnam-si, South Korea | Biotech | Commercial | VIEW |
| 76. |  Aptose Biosciences Inc. Toronto, Canada | Biotech | Phase 2 | VIEW |
| 77. |  Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA | Biotech | Phase 2 | VIEW |
| 78. |  Aragen Life Sciences Hyderabad, India | CRO | Discovery | VIEW |
| 79. |  Arcus Biosciences Hayward, United States | Biotech | Phase 3 | VIEW |
| 80. |  | CDMO | Commercial | VIEW |
| 81. |  Aristopharma Ltd. Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 82. |  | CRO | Commercial | VIEW |
| 83. |  Artios Pharma Cambridge, United Kingdom | Biotech | Phase 2 | VIEW |
| 84. |  Artiva Biotherapeutics San Diego, USA | Biotech | Phase 2 | VIEW |
| 85. |  Arvinas, Inc. New Haven, Connecticut, United States | Biotech | Phase 1-3 | VIEW |
| 86. |  Aryastha Life Sciences Hyderabad, India | CRO | Discovery | VIEW |
| 87. |  AryoGen Pharmed Karaj, Iran | Biotech | Commercial | VIEW |
| 88. |  Ascentage Pharma Suzhou, China | Biotech | Commercial | VIEW |
| 89. |  AskGene Camarillo, California, United States | Biotech | Phase 3 | VIEW |
| 90. |  Aspen Global Incorporated Grand Bay, Mauritius | Pharma | Commercial | VIEW |
| 91. |  Aspen Pharmacare Holdings Limited uMhlanga, South Africa | Pharma | Commercial (Focus on post-patent branded generics rather than R&D pipeline) | VIEW |
| 92. |  Assertio Holdings, Inc. Lake Forest, USA | Pharma | Commercial | VIEW |
| 93. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 94. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 95. |  Atara Biotherapeutics, Inc. Thousand Oaks, California, USA | Biotech | Clinical | VIEW |
| 96. |  | Digital Health | Discovery | VIEW |
| 97. |  Aurefluidics Shanghai, China | Biotech | Commercial | VIEW |
| 98. |  Aurigene Pharmaceutical Services Limited Bengaluru, India | CDMO | Commercial | VIEW |
| 99. |  Aurigon Labs Munich, Germany | CRO | Preclinical | VIEW |
| 100. |  Aurobindo Pharma Limited Hyderabad, India | Pharma | Commercial | VIEW |
| 101. |  AutoCruitment Atlanta, Georgia, USA | Digital Health | Commercial | VIEW |
| 102. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 103. |  Avalon Pharma (Middle East Pharmaceutical Industries Co.) Riyadh, Saudi Arabia | Pharma | Commercial | VIEW |
| 104. |  Avant Santé Research Center S.A. de C.V. Monterrey, Mexico | CRO | N/A | VIEW |
| 105. |  Avastus Preclinical Services Cambridge, USA | CRO | Discovery | VIEW |
| 106. |  Avegen Health London, United Kingdom | Digital Health | Commercial | VIEW |
| 107. |  Avenzo Therapeutics San Diego, USA | Biotech | Phase 2 | VIEW |
| 108. |  Axbio (Anxuyuan Biotechnology) Shenzhen, China | Diagnostics | Commercial | VIEW |
| 109. |  Axis Clinicals Hyderabad, India | CRO | Commercial | VIEW |
| 110. |  Azidus Laboratories Ghana Tema, Ghana | CRO | - | VIEW |
| 111. |  Azurity Pharmaceuticals Woburn, USA | Pharma | Commercial | VIEW |
| 112. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 113. |  | Diagnostics | Commercial | VIEW |
| 114. |  BIOCAD Saint Petersburg, Russia | Biotech | Commercial | VIEW |
| 115. |  | Biotech | Discovery | VIEW |
| 116. |  BNPLAB Co., Ltd. Seoul, South Korea | CRO | Commercial | VIEW |
| 117. |  BPS Bioscience, Inc. San Diego, California, United States | Biotech | Discovery | VIEW |
| 118. |  BSP Pharmaceuticals S.p.A. Latina, Italy | CDMO | Commercial | VIEW |
| 119. |  Bachem Holding AG Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 120. |  Barreleye Seoul, South Korea | MedTech | Commercial | VIEW |
| 121. |  Batavia Biosciences Leiden, Netherlands | CDMO | N/A | VIEW |
| 122. |  Bavarian Nordic A/S Hellerup, Denmark | Biotech | Commercial | VIEW |
| 123. |  | Pharma | Discovery through Commercial | VIEW |
| 124. |  BeBetter Med Inc. Guangzhou, China | Biotech | Commercial | VIEW |
| 125. |  BeOne Medicines Basel, Switzerland (redomiciled May 2025); originally Cambridge, Massachusetts | Pharma | Commercial and Clinical (Phase 1-3) | VIEW |
| 126. |  BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025) | Pharma | Phase 1-3 and Commercial | VIEW |
| 127. |  Beacon Pharmaceuticals PLC Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 128. |  Beacon Scientific Consulting Ltd Cambridge, United Kingdom | CRO | - | VIEW |
| 129. |  Beckman Coulter Life Sciences Indianapolis, USA | MedTech | Commercial | VIEW |
| 130. |  Becton Dickinson Franklin Lakes, New Jersey, USA | MedTech | Commercial | VIEW |
| 131. |  Beijing Captain Science Co., Ltd. Beijing, China | CRO | - | VIEW |
| 132. |  Beijing D-VIEW Intelligence Technology Beijing, China | MedTech | Commercial | VIEW |
| 133. |  Beijing Haibu Pharmaceutical Technology Co., Ltd. Beijing, China | CRO | Discovery | VIEW |
| 134. |  Beijing Highthink Pharmaceutical Technology Service Co., Ltd. Beijing, China | CRO | Service Provider | VIEW |
| 135. |  Beijing Sungen Biomedical Technology Co., Ltd. Beijing, China | Biotech | Phase 2 | VIEW |
| 136. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 137. |  Benitec Biopharma Inc. Hayward, California, USA | Biotech | Phase 1b/2a (BB-301), Preclinical (other programs) | VIEW |
| 138. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 139. |  Berlin-Chemie AG Berlin, Germany | Pharma | Commercial | VIEW |
| 140. |  Beta Drugs Limited Panchkula, India | Pharma | Commercial | VIEW |
| 141. |  Bexon Clinical Consulting, LLC Upper Montclair, New Jersey, USA | CRO | - | VIEW |
| 142. |  Beyond Drug Development Brisbane, Australia | CRO | Discovery | VIEW |
| 143. |  Bharat Biotech Hyderabad, India | Biotech | Commercial | VIEW |
| 144. |  | CDMO | Commercial | VIEW |
| 145. |  Bicycle Therapeutics plc Cambridge, United Kingdom | Biotech | Phase 2 | VIEW |
| 146. |  Binex Co., Ltd. Busan, South Korea | CDMO | Commercial | VIEW |
| 147. |  Bio Usawa Inc. San Mateo, USA / Kigali, Rwanda | Biotech | Preclinical | VIEW |
| 148. |  Bio-Rad Laboratories, Inc. Hercules, California, USA | Diagnostics | Commercial | VIEW |
| 149. |  BioAgilytix Labs Durham, NC, USA | CRO | Private Equity-Backed | VIEW |
| 150. |  BioCARTIS Mechelen, Belgium | Diagnostics | Commercial | VIEW |
| 151. |  BioChain Institute Inc. Newark, California, USA | Biotech | Commercial | VIEW |
| 152. |  BioDuro-Sundia Irvine, USA | CDMO | Commercial | VIEW |
| 153. |  BioInvent International AB Lund, Sweden | Biotech | Phase 2 | VIEW |
| 154. |  BioLineRx Ltd. Modiin, Israel | Biotech | Commercial | VIEW |
| 155. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 156. |  | Biotech | Phase 1-3 | VIEW |
| 157. |  BioNTech SE Mainz, Germany | Biotech | Commercial | VIEW |
| 158. |  BioOra Limited Wellington, New Zealand | Biotech | Phase 2 | VIEW |
| 159. |  BioScan AI (BioScanAI Innovative Solutions Private Limited) Navi Mumbai, India | Diagnostics | Commercial | VIEW |
| 160. |  Biochemome Research International, Inc. San Diego, USA | CRO | Discovery | VIEW |
| 161. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 162. |  Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Beijing, China | Biotech | Phase 2 | VIEW |
| 163. |  Biohaven Ltd. New Haven, USA | Biotech | Phase 3 | VIEW |
| 164. |  Biolab Samut Prakan, Thailand | CDMO | Commercial | VIEW |
| 165. |  Biomea Fusion San Carlos, USA | Biotech | Phase 2 | VIEW |
| 166. |  Bion Healthcare Private Limited Ahmedabad, India | CDMO | Commercial | VIEW |
| 167. |  Bioneer A/S Hørsholm, Denmark | CRO | Discovery | VIEW |
| 168. |  Biosynth Staad, Switzerland | CDMO | Discovery | VIEW |
| 169. |  Blau Farmacêutica S.A. Cotia, Brazil | Pharma | Commercial | VIEW |
| 170. |  BlossomHill Therapeutics San Diego, USA | Biotech | Phase 1 | VIEW |
| 171. |  BlueBridge Technologies Dublin, Ireland | Digital Health | Commercial | VIEW |
| 172. |  Blueprint Medicines Cambridge, USA | Biotech | Commercial | VIEW |
| 173. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 174. |  Boostimmune Seoul, South Korea | Biotech | Preclinical | VIEW |
| 175. |  Boryung Seoul, South Korea | Pharma | Commercial | VIEW |
| 176. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 177. |  Boston Scientific Marlborough, USA | MedTech | Commercial | VIEW |
| 178. |  Bracco Imaging S.p.A. Milan, Italy | Pharma | Commercial | VIEW |
| 179. |  Bracco Sine Pharmaceutical Corp. Ltd. Shanghai, China | Pharma | Commercial | VIEW |
| 180. |  | MedTech | Commercial/Clinical Development | VIEW |
| 181. |  BridgeBio Oncology Therapeutics, Inc. South San Francisco, USA | Biotech | Phase 1 | VIEW |
| 182. |  Bright Peak Therapeutics Allschwil, Switzerland | Biotech | Phase 1/2a | VIEW |
| 183. |  Brightonix Imaging Seoul, South Korea | MedTech | Commercial | VIEW |
| 184. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 185. |  | Digital Health | Commercial | VIEW |
| 186. |  Broad Institute of MIT and Harvard Cambridge, USA | Biotech | Discovery | VIEW |
| 187. |  Bukwang Pharmaceutical Co., Ltd. Seoul, South Korea | Pharma | Phase 2 | VIEW |
| 188. |  BunyaVax Lelystad, Netherlands | Biotech | Phase 1 | VIEW |
| 189. |  Byondis Nijmegen, Netherlands | Biotech | Phase 1 | VIEW |
| 190. |  C&R Research Inc. Seoul, South Korea | CRO | N/A | VIEW |
| 191. |  C-Ray Therapeutics Chengdu, China | CDMO | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 192. |  | Digital Health | Commercial | VIEW |
| 193. |  CBSET, Inc. Lexington, USA | CRO | Discovery | VIEW |
| 194. |  CC&I Research Co., Ltd. Seoul, South Korea | CRO | - | VIEW |
| 195. |  CCDRD AG Hoppegarten, Germany | CRO | N/A | VIEW |
| 196. |  CCL Pharmaceuticals (Pvt.) Limited Lahore, Pakistan | Pharma | Commercial | VIEW |
| 197. |  CCS Associates, Inc. San Jose, California, USA | CRO | - | VIEW |
| 198. |  CDR-Life Schlieren, Zurich, Switzerland | Biotech | Phase 1 | VIEW |
| 199. |  CEA (Commissariat à l'énergie atomique et aux énergies alternatives) Paris and Gif-sur-Yvette, France | Biotech | Discovery | VIEW |
| 200. |  CERNO Eeklo (Ghent region), Belgium | CRO | Commercial | VIEW |
| 201. |  CG Oncology, Inc. Irvine, USA | Biotech | Phase 3 | VIEW |
| 202. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 203. |  | CRO | Commercial | VIEW |
| 204. |  CMC Compliance Services, LLC Bridgewater, New Jersey, USA | CRO | Commercial | VIEW |
| 205. |  CMC Pharmaceuticals Solon, Ohio, USA | CDMO | Commercial | VIEW |
| 206. |  CODAN Medizinische Geräte GmbH Lensahn, Germany | MedTech | - | VIEW |
| 207. |  | Biotech | Preclinical | VIEW |
| 208. |  CRUK Scotland Institute Glasgow, United Kingdom | Biotech | Discovery | VIEW |
| 209. |  CSPC Pharmaceutical Group Limited Shijiazhuang, China | Pharma | Commercial | VIEW |
| 210. |  | CRO | Commercial | VIEW |
| 211. |  Cactus Life Sciences Princeton, USA | CRO | - | VIEW |
| 212. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 213. |  | CRO | N/A | VIEW |
| 214. |  Calico Life Sciences South San Francisco, United States | Biotech | Phase 2 | VIEW |
| 215. |  Calidi Biotherapeutics San Diego, USA | Biotech | Phase 2 | VIEW |
| 216. |  | Biotech | Commercial | VIEW |
| 217. |  CanariaBio Inc. Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 218. |  | Biotech | Phase 1 - Phase 2 | VIEW |
| 219. |  Captor Therapeutics Wroclaw, Poland | Biotech | Preclinical | VIEW |
| 220. |  Capulus Therapeutics LLC San Francisco, United States | Biotech | Preclinical | VIEW |
| 221. |  Carbogen Amcis Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 222. |  Care Access Boston, Massachusetts | CRO | Commercial | VIEW |
| 223. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 224. |  Caritas Healthcare Private Limited Ahmedabad, India | Pharma | Commercial | VIEW |
| 225. |  Carrick Therapeutics Dublin, Ireland | Biotech | Phase 2 | VIEW |
| 226. |  Castle Biosciences, Inc. Friendswood, USA | Diagnostics | Commercial | VIEW |
| 227. |  Catalent, Inc. Tampa, Florida, USA | CDMO | Commercial | VIEW |
| 228. |  Cdymax (India) Pharma Private Limited Bangalore, India | CDMO | Commercial | VIEW |
| 229. |  Cell-Tx Seoul, South Korea | Biotech | Preclinical | VIEW |
| 230. |  CellCarta Montreal, Canada | CRO | N/A | VIEW |
| 231. |  Cellares South San Francisco, USA | CDMO | Commercial | VIEW |
| 232. |  Cellectar Biosciences, Inc. Florham Park, USA | Biotech | Phase 2 | VIEW |
| 233. |  | Biotech | Phase 2 | VIEW |
| 234. |  Cellestia Biotech AG Basel, Switzerland | Biotech | Phase 2 | VIEW |
| 235. |  Cellipont Bioservices The Woodlands, Texas, USA | CDMO | Commercial | VIEW |
| 236. |  Celltrion Incheon, South Korea | Biotech | Commercial | VIEW |
| 237. |  Celon Pharma Łomianki, Poland | Biotech | Phase 3 | VIEW |
| 238. |  Celularity Inc Florham Park, New Jersey, USA | Biotech | Phase 1/2 and Phase 2 | VIEW |
| 239. |  Center for Genetic Engineering and Biotechnology (CIGB) Havana, Cuba | Biotech | Commercial | VIEW |
| 240. |  Center of Molecular Immunology (CIM) Havana, Cuba | Biotech | Commercial | VIEW |
| 241. |  Centogene Rostock, Germany | Diagnostics | Preclinical | VIEW |
| 242. |  Centricity Research Columbus, Georgia, USA and Toronto, Canada | CRO | Commercial | VIEW |
| 243. |  Cepheid Sunnyvale, California, USA | Diagnostics | Commercial | VIEW |
| 244. |  Cerbios-Pharma SA Barbengo-Lugano, Switzerland | CDMO | Preclinical|Clinical|Commercial | VIEW |
| 245. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 246. |  Certara Princeton, New Jersey, USA | Digital Health | N/A | VIEW |
| 247. |  Changchun GeneScience Pharmaceutical Co., Ltd. Changchun, China | Biotech | Clinical | VIEW |
| 248. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 249. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 250. |  ChemPartner Guangzhou, China | CRO | Discovery | VIEW |
| 251. |  Chemo de Mexico Mexico City, Mexico | Pharma | Commercial | VIEW |
| 252. |  Chengdu Kanghong Pharmaceutical Group Chengdu, China | Pharma | Commercial | VIEW |
| 253. |  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ) Lianyungang/Nanjing, China | Pharma | Commercial | VIEW |
| 254. |  China Isotope & Radiation Corporation (CIRC) Beijing, China | Pharma | Commercial | VIEW |
| 255. |  China Meheco Corporation Beijing, China | Pharma | Commercial | VIEW |
| 256. |  China Resources Double-Crane Pharmaceutical Co., Ltd. Beijing, China | Pharma | Commercial | VIEW |
| 257. |  China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Shenzhen, China | Pharma | Commercial | VIEW |
| 258. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 259. |  Chongqing PegBio Biotechnology Co., Ltd. Chongqing, China | Biotech | Phase 3 | VIEW |
| 260. |  Choose Life Biotech SA Bellinzona, Switzerland | Biotech | Preclinical | VIEW |
| 261. |  ChuanXin Biomedicine Suzhou, China | Biotech | Phase 1 | VIEW |
| 262. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 263. |  Chugai Pharmaceutical Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 264. |  Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) New Taipei City, Taiwan | CDMO | Commercial | VIEW |
| 265. |  Ciencia Research AB Stockholm, Sweden | CRO | Private Equity-Backed | VIEW |
| 266. |  Cipla Limited Mumbai, India | Pharma | Commercial | VIEW |
| 267. |  Circio Holding ASA Lysaker, Norway | Biotech | Phase 1/2 | VIEW |
| 268. |  Citi Pharma Limited Lahore, Pakistan | Pharma | Commercial | VIEW |
| 269. |  Clasp Therapeutics Rockville, Maryland, USA | Biotech | Phase 1 | VIEW |
| 270. |  ClearNote Health San Diego, USA | Diagnostics | Commercial | VIEW |
| 271. |  Cliantha Research Ahmedabad, India | CRO | Commercial | VIEW |
| 272. |  ClinChoice Fort Washington, USA / Shanghai, China | CRO | N/A | VIEW |
| 273. |  ClinSync Clinical Research Pvt. Ltd. Hyderabad, India | CRO | - | VIEW |
| 274. |  CliniExperts Research Services New Delhi, India | CRO | Commercial | VIEW |
| 275. |  Clinical Horizons Research Inc. Leonia, New Jersey, USA | CRO | Commercial | VIEW |
| 276. |  Clinical Outcomes Solutions Chicago, USA / Folkestone, UK | CRO | - | VIEW |
| 277. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 278. |  Clinical Service Center (CSC) Suzhou, China | CRO | Commercial | VIEW |
| 279. |  Clinovi Research Pune, India | CRO | Commercial | VIEW |
| 280. |  Clonz Biotech Pvt Ltd Hyderabad, India | CDMO | Clinical | VIEW |
| 281. |  | Pharma | Commercial | VIEW |
| 282. |  Coherus BioSciences, Inc. Redwood City, USA | Biotech | Commercial | VIEW |
| 283. |  Compal Electronics, Inc. Taipei, Taiwan | MedTech | Phase 2 | VIEW |
| 284. |  Constructor Group Schaffhausen, Switzerland | Biotech | Preclinical | VIEW |
| 285. |  Coral Healthcare Beijing, China | Digital Health | Commercial | VIEW |
| 286. |  Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, USA | Biotech | Phase 3 | VIEW |
| 287. |  Corcept Therapeutics Redwood City, USA | Pharma | Commercial | VIEW |
| 288. |  Covance Princeton, New Jersey, USA | CRO | N/A - Service provider, not drug developer | VIEW |
| 289. |  Crescent Biopharma, Inc. Waltham, USA | Biotech | Phase 1/2 | VIEW |
| 290. |  Crescent Pharma Basingstoke, United Kingdom | Pharma | Commercial | VIEW |
| 291. |  Crixmor LLC Malvern, Pennsylvania, USA | Pharma | Discovery | VIEW |
| 292. |  Crown Bioscience San Diego, California, USA | CRO | Discovery | VIEW |
| 293. |  | Biotech | Phase 1 | VIEW |
| 294. |  Cullinan Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 295. |  CuraTeQ Biologics Hyderabad, India | Biotech | Commercial | VIEW |
| 296. |  Curadev Pharma Pvt Ltd Noida, India | Biotech | Phase 1 | VIEW |
| 297. |  Curasight Copenhagen, Denmark | Biotech | Phase 1-2 Clinical | VIEW |
| 298. |  Curatis Liestal, Switzerland | Pharma | Phase 3 | VIEW |
| 299. |  | Biotech | Phase 2 | VIEW |
| 300. |  Curebase San Francisco, USA | Digital Health | Commercial | VIEW |
| 301. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 302. |  Curis, Inc. Lexington, USA | Biotech | Phase 1/2 | VIEW |
| 303. |  | Pharma | Commercial | VIEW |
| 304. |  Curocell Inc. Daejeon, South Korea | Biotech | Commercial | VIEW |
| 305. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 306. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 307. |  | Digital Health | Service Provider | VIEW |
| 308. |  Cytiva Marlborough, Massachusetts, USA | Biotech | Commercial | VIEW |
| 309. |  CytoAgents Pittsburgh, USA | Biotech | Phase 2 | VIEW |
| 310. |  CytoDyn Inc Vancouver, Washington | Biotech | Phase 2 clinical | VIEW |
| 311. |  CytoImmune Therapeutics Duarte, USA | Biotech | Phase 1 | VIEW |
| 312. |  CytoSen Therapeutics Orlando (Winter Springs), Florida, USA | Biotech | Phase 2 | VIEW |
| 313. |  CytoTools AG Heidelberg, Germany | Biotech | Phase 3 | VIEW |
| 314. |  | Biotech | Phase 2 | VIEW |
| 315. |  Cytochem Inc. Montreal, Canada | CRO | - | VIEW |
| 316. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 317. |  CytomX Therapeutics, Inc. South San Francisco, California, United States | Biotech | Phase 1 (clinical), Preclinical (discovery collaborations) | VIEW |
| 318. |  Cytomos Edinburgh, United Kingdom | Biotech | Commercial | VIEW |
| 319. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 320. |  Cytorex Biosciences Weston, Florida, USA | Biotech | Preclinical | VIEW |
| 321. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 322. |  | Biotech | Phase I/II - Phase II | VIEW |
| 323. |  Cytovia Therapeutics Aventura, Florida, USA | Biotech | Phase 1/2 | VIEW |
| 324. |  DP Clinical, Inc. Rockville, Maryland, USA | CRO | - | VIEW |
| 325. |  Daicel Chiral Technologies Hyderabad, India (Regional HQ); West Chester, PA, USA (Global HQ) | CDMO | Commercial | VIEW |
| 326. |  Daichi Kasei Co., Ltd. Fukusaki, Japan | CDMO | Commercial | VIEW |
| 327. |  Daiichi Sankyo Chuo, Tokyo, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 328. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 329. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 330. |  Danaher Corporation Washington, D.C., USA | Biotech | N/A | VIEW |
| 331. |  Datar Cancer Genetics Nashik, India | Diagnostics | Commercial | VIEW |
| 332. |  Day One Biopharmaceuticals Brisbane, United States | Biotech | Commercial | VIEW |
| 333. |  Debiopharm Lausanne, Switzerland | Biotech | Phase 1, Phase 2, Phase 3 | VIEW |
| 334. |  Deep Intelligent Pharma (DIP) Singapore | Digital Health | Discovery | VIEW |
| 335. |  Delfi Diagnostics Palo Alto, USA | Diagnostics | Commercial | VIEW |
| 336. |  Delve Health Minneapolis, USA | Digital Health | Commercial | VIEW |
| 337. |  Delve-RW LLC Franklin, Massachusetts, USA | Digital Health | Commercial | VIEW |
| 338. |  Demedica San Pedro Sula, Honduras | CRO | Commercial | VIEW |
| 339. |  Dendreon Pharmaceuticals Seal Beach, USA | Biotech | Commercial | VIEW |
| 340. |  DermaSensor Inc. Miami, USA | MedTech | Commercial | VIEW |
| 341. |  DevaCell, Inc. San Diego, USA | Biotech | Preclinical | VIEW |
| 342. |  Development Center for Biotechnology (DCB) Taipei, Taiwan | Biotech | Preclinical | VIEW |
| 343. |  Dexa Medica Tangerang, Indonesia | Pharma | Commercial | VIEW |
| 344. |  Dexcel Pharma Or Akiva, Israel | Pharma | Commercial | VIEW |
| 345. |  Divi's Laboratories Limited Hyderabad, India | CDMO | Commercial | VIEW |
| 346. |  Dizal Pharmaceutical Shanghai, China | Pharma | Commercial | VIEW |
| 347. |  Dompé Farmaceutici Milan, Italy | Biotech | Commercial | VIEW |
| 348. |  Dong-A Socio Holdings Co., Ltd. Seoul, South Korea | Pharma | Commercial | VIEW |
| 349. |  Dr. Reddy's Laboratories Ltd. Hyderabad, India | Pharma | Commercial | VIEW |
| 350. |  Drug & Biotechnology Development, LLC Clearwater, USA | CRO | Commercial | VIEW |
| 351. |  Duality Biologics Shanghai, China | Biotech | Phase 3 | VIEW |
| 352. |  Duopharma Biotech Berhad Kuala Lumpur, Malaysia | Pharma | Commercial | VIEW |
| 353. |  E-Flask Seongnam, South Korea | Biotech | Phase 1 | VIEW |
| 354. |  | CRO | Commercial | VIEW |
| 355. |  EIPICO 10th of Ramadan City, Egypt | Pharma | Phase 3 | VIEW |
| 356. |  EIPICO 10th of Ramadan City, Egypt | Pharma | Phase 3 | VIEW |
| 357. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 358. |  EPS Corporation Shinjuku-ku, Tokyo, Japan | CRO | N/A | VIEW |
| 359. |  | CDMO | Commercial | VIEW |
| 360. |  Ecodi Meditech Pte Ltd Singapore, Singapore | CRO | Discovery|Preclinical|Phase 1|Phase 2 | VIEW |
| 361. |  Eczacıbaşı Group Istanbul, Turkey | Pharma | Commercial | VIEW |
| 362. |  Eczacıbaşı Pharmaceutical and Industrial Investment Co. Istanbul, Turkey | Pharma | Commercial | VIEW |
| 363. |  Edge Therapeutics, Inc. Princeton, New Jersey, USA | Biotech | Phase 3 | VIEW |
| 364. |  Efficient Pharma Management Corp. (EffPha) Taipei City, Taiwan | CRO | Commercial | VIEW |
| 365. |  EirGenix, Inc. New Taipei City, Taiwan | CDMO | Commercial | VIEW |
| 366. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 367. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 368. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 369. |  Eisai Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 370. |  Eisai Pharmaceuticals India Mumbai, India | Pharma | Commercial | VIEW |
| 371. |  Elevar Therapeutics Fort Lee, USA | Biotech | Phase 3 | VIEW |
| 372. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 373. |  Elite Medical Global Limited Kwun Tong, Hong Kong | Diagnostics | - | VIEW |
| 374. |  Elixiron Immunotherapeutics Taipei, Taiwan | Biotech | Phase 2 | VIEW |
| 375. |  Ellipses Pharma London, United Kingdom | Biotech | Phase 1/2 | VIEW |
| 376. |  Emblem AI San Francisco, USA | Digital Health | Commercial | VIEW |
| 377. |  Emmes Group Rockville, Maryland, USA | CRO | N/A | VIEW |
| 378. |  | CRO | Commercial | VIEW |
| 379. |  Empresa de Laboratorios AICA La Lisa, Havana, Cuba | Pharma | Commercial | VIEW |
| 380. |  Enlivex Therapeutics Ltd. Ness Ziona, Israel | Biotech | Phase 2 | VIEW |
| 381. |  Ensem Therapeutics Waltham, MA, USA | Biotech | Phase 1/2 | VIEW |
| 382. |  | Biotech | Preclinical | VIEW |
| 383. |  Enzo Biochem, Inc. Farmingdale, New York, USA | Biotech | Discovery | VIEW |
| 384. |  Equitable Technologies Inc. Boston, USA | Diagnostics | Commercial | VIEW |
| 385. |  Ergomed Guildford, United Kingdom | CRO | Commercial | VIEW |
| 386. |  Escientia Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 387. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 388. |  Estetra SRL Liège, Belgium | Biotech | Commercial | VIEW |
| 389. |  Esteve Healthcare Barcelona, Spain | Pharma | Commercial | VIEW |
| 390. |  | CRO | Commercial | VIEW |
| 391. |  Eugia US LLC East Windsor, New Jersey, USA | Pharma | Commercial | VIEW |
| 392. |  Eurofarma Itapevi, São Paulo, Brazil | Pharma | Multiple stages (Discovery to Commercial) | VIEW |
| 393. |  Eurofins BioPharma Product Testing (BPT) Luxembourg City, Luxembourg | CRO | Commercial | VIEW |
| 394. |  Eurofins BioPharma Product Testing (Canada) Mississauga/Toronto, Canada | CRO | Commercial | VIEW |
| 395. |  Eurofins Central Laboratory Lancaster, PA, USA | CRO | - | VIEW |
| 396. |  Eurofins PHAST GmbH Homburg, Germany | CRO | Commercial | VIEW |
| 397. |  Eurofins Scientific (US Division) Luxembourg City, Luxembourg | CRO | Commercial | VIEW |
| 398. |  Everest Medicines Shanghai, China | Biotech | Commercial | VIEW |
| 399. |  Evinova Cambridge, United Kingdom (Regional offices in North America, Europe, and Asia-Pacific) | Digital Health | Commercial | VIEW |
| 400. |  | CRO | Discovery | VIEW |
| 401. |  Evonik Industries AG Essen, Germany | CDMO | Commercial | VIEW |
| 402. |  Evopoint Biosciences Suzhou, China | Biotech | Commercial (NDA Stage) | VIEW |
| 403. |  Evotec SE Hamburg, Germany | CDMO | Commercial | VIEW |
| 404. |  Evox Therapeutics Oxford, United Kingdom | Biotech | Preclinical | VIEW |
| 405. |  | Biotech | Commercial | VIEW |
| 406. |  Extrovis Baar, Switzerland | CDMO | Commercial | VIEW |
| 407. |  FNCT Biotech Seongnam-si, South Korea | Biotech | Preclinical | VIEW |
| 408. |  FORE Biotherapeutics Philadelphia, USA | Biotech | Phase 2 | VIEW |
| 409. |  | Diagnostics | Preclinical | VIEW |
| 410. |  Fareva Luxembourg, Luxembourg | CDMO | N/A | VIEW |
| 411. |  Faron Pharmaceuticals Turku, Finland | Biotech | Phase 2 | VIEW |
| 412. |  Fate Therapeutics, Inc. San Diego, USA | Biotech | Phase 1 | VIEW |
| 413. |  Feldan Therapeutics Québec City, Canada | Biotech | Preclinical | VIEW |
| 414. |  FenoMark Diagnostics AB Solna, Sweden | Diagnostics | Discovery | VIEW |
| 415. |  Ferozsons Laboratories Limited Lahore, Pakistan | Pharma | Commercial | VIEW |
| 416. |  | CDMO | Commercial | VIEW |
| 417. |  Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil | Pharma | Commercial | VIEW |
| 418. |  Fishfa Biogenics Rajkot, India | Biotech | Commercial | VIEW |
| 419. |  Flare Therapeutics Cambridge, MA, USA | Biotech | Phase 1-1B | VIEW |
| 420. |  Floratek Pharma SA Belmont-sur-Lausanne, Switzerland | Biotech | Preclinical | VIEW |
| 421. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 422. |  For Benefit Medicines Sydney, Australia | Pharma | Commercial | VIEW |
| 423. |  Forma Therapeutics Inc Watertown, USA | Biotech | Phase 3 | VIEW |
| 424. |  Fortrea Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 425. |  Fosun Pharma Shanghai, China | Pharma | Commercial | VIEW |
| 426. |  Foundation Medicine, Inc. Boston, Massachusetts, USA | Diagnostics | Commercial | VIEW |
| 427. |  Francis Medical Maple Grove, USA | MedTech | Commercial | VIEW |
| 428. |  Free Market Health Pittsburgh, USA | Digital Health | Series B | VIEW |
| 429. |  Fresenius Kabi Bad Homburg, Germany | Pharma | Commercial | VIEW |
| 430. |  Freyr Solutions Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 431. |  Frontage Laboratories (Shanghai) Co., Ltd. Shanghai, China | CRO | Commercial | VIEW |
| 432. |  Frontage Laboratories, Inc. Exton, USA | CRO | Commercial | VIEW |
| 433. |  Frontier Medicines South San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 434. |  Fujifilm Diosynth Biotechnologies Morrisville, North Carolina, USA | CDMO | Commercial | VIEW |
| 435. |  Fusion Antibodies Belfast, Northern Ireland, United Kingdom | CRO | Discovery|Preclinical|Clinical (clients' projects) | VIEW |
| 436. |  Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 437. |  FyoniBio GmbH Berlin, Germany | CRO | N/A | VIEW |
| 438. |  G&L Scientific Marlow, United Kingdom | CRO | Commercial | VIEW |
| 439. |  GE HealthCare Chicago, USA (Global); Lindesnes/Oslo, Norway (PDx R&D/Manufacturing) | MedTech | Commercial | VIEW |
| 440. |  | Pharma | Phase 1|Phase 2|Commercial | VIEW |
| 441. |  GRAIL, Inc. Menlo Park, USA | Diagnostics | Commercial | VIEW |
| 442. |  GSK plc London, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 443. |  Galapagos NV Mechelen, Belgium | Biotech | Phase 2 | VIEW |
| 444. |  Galenicap BV Brussels, Belgium | Biotech | Phase 2 | VIEW |
| 445. |  Gan & Lee Pharmaceuticals Beijing, China | Pharma | Commercial | VIEW |
| 446. |  GemPharmatech Co., Ltd. Nanjing, China | CRO | Discovery | VIEW |
| 447. |  GenAns Biotech Beijing, China | Biotech | Preclinical | VIEW |
| 448. |  GenLumina Leiden, Netherlands | Biotech | Preclinical | VIEW |
| 449. |  Gene Oasis Singapore, Singapore | Biotech | Clinical | VIEW |
| 450. |  GeneBiology, Inc. Research Triangle Park, North Carolina, USA | Pharma | Clinical | VIEW |
| 451. |  GeneScience Pharmaceuticals Co., Ltd. (GenSci) Changchun, China | Biotech | Commercial | VIEW |
| 452. |  | Biotech | - | VIEW |
| 453. |  Genedata Basel, Switzerland | Digital Health | - | VIEW |
| 454. |  Genelytica Sp. z o.o. Łomża, Poland | CRO | Discovery | VIEW |
| 455. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 456. |  | Biotech | Discovery | VIEW |
| 457. |  Genes2Me Private Limited Gurgaon, India | Diagnostics | Commercial | VIEW |
| 458. |  Genfarma Joint Stock Company Hanoi, Vietnam | Biotech | Commercial | VIEW |
| 459. |  Genfoquest Analytica Izmir, Türkiye | Digital Health | Discovery | VIEW |
| 460. |  Genialis, Inc. Boston, USA | Digital Health | Discovery | VIEW |
| 461. |  Genmab Copenhagen, Denmark | Biotech | Commercial | VIEW |
| 462. |  | Digital Health | Commercial | VIEW |
| 463. |  Genuine Research Center (GRC) Cairo, Egypt | CRO | - | VIEW |
| 464. |  Getz Pharma Karachi, Pakistan | Pharma | Commercial | VIEW |
| 465. |  Gland Pharma Hyderabad, India | CDMO | Commercial | VIEW |
| 466. |  Glenmark Pharmaceuticals Mumbai, India | Pharma | Commercial | VIEW |
| 467. |  Global Clinix LLC Miami, Florida, USA | CRO | Commercial | VIEW |
| 468. |  Global Life Sciences Alliance Philadelphia, PA, USA | CRO | Commercial | VIEW |
| 469. |  Google (Google DeepMind / Isomorphic Labs) London, United Kingdom | Biotech | Preclinical | VIEW |
| 470. |  Grand Pharmaceutical Group Wuhan, China | Pharma | Commercial | VIEW |
| 471. |  Granules India Limited Hyderabad, India | CDMO | Commercial | VIEW |
| 472. |  Grit Biotechnology Shenzhen, China | Biotech | Phase 2 | VIEW |
| 473. |  Gypto Pharma Khanka, Qalyubia, Egypt | Pharma | Commercial | VIEW |
| 474. |  HCW Biologics Inc. Miramar, Florida, USA | Biotech | Phase 2 | VIEW |
| 475. |  HERVolution Therapeutics Copenhagen, Denmark | Biotech | Preclinical | VIEW |
| 476. |  HLB PEP Co., Ltd. Gwangju, South Korea | Biotech | Preclinical | VIEW |
| 477. |  | Biotech | Discovery to Phase III | VIEW |
| 478. |  Haisco Pharmaceutical Group Shannan, China | Pharma | Phase 3 | VIEW |
| 479. |  Haisco Pharmaceutical Group Co., Ltd. Shannan, China | Pharma | Phase 3 | VIEW |
| 480. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 481. |  Hanmi Pharmaceutical Co., Ltd. Seoul, South Korea | Pharma | Commercial | VIEW |
| 482. |  Hansa Biopharma Lund, Sweden | Biotech | Commercial | VIEW |
| 483. |  Hansoh Pharmaceutical Group Co., Ltd. Shanghai, China | Pharma | Phase 3 | VIEW |
| 484. |  Harbour BioMed Shanghai, China | Biotech | Phase 3 | VIEW |
| 485. |  Harman Finochem Ltd. Mumbai, India | CDMO | Commercial | VIEW |
| 486. |  Harvest Integrated Research Organization Shanghai, China | CRO | N/A - Service provider, not drug developer | VIEW |
| 487. |  Hayya Life Science Jakarta, Indonesia | CRO | Commercial | VIEW |
| 488. |  | Biotech | Phase 3 | VIEW |
| 489. |  Health Decision Technologies, LLC Oakland, USA | Digital Health | Commercial | VIEW |
| 490. |  Health Hope Pharma Hong Kong, Hong Kong | Pharma | Phase 3 | VIEW |
| 491. |  Hedera Dx Epalinges, Switzerland | Diagnostics | Commercial | VIEW |
| 492. |  Heligenics Phoenix, Arizona, USA | Biotech | Discovery | VIEW |
| 493. |  Hemerion Therapeutics Villeneuve d'Ascq, France | Biotech | Phase 1/2 | VIEW |
| 494. |  | Pharma | Commercial | VIEW |
| 495. |  HepaRegeniX GmbH Tübingen, Germany | Biotech | Phase 2 | VIEW |
| 496. |  | Pharma | Commercial | VIEW |
| 497. |  Hetero Drugs Limited Hyderabad, India | Pharma | Commercial | VIEW |
| 498. |  Hetero Healthcare Ltd Hyderabad, India | Pharma | Commercial | VIEW |
| 499. |  Hexal AG Holzkirchen, Germany | Pharma | Commercial | VIEW |
| 500. |  HighField Biopharmaceuticals Hangzhou, China | Biotech | Phase 1 | VIEW |